Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination by Müller, K, Gibbins, M, Roberts, M, Reyes-Sandoval, A, Hill, AVS, Draper, SJ, Matuschewski, K, Silvie, O, Hafalla, JCR

The importance of the immunodominant CD8+ T cell epitope of Plasmodium berghei circumsporozoite protein in parasite- and vaccine-induced protection by Gibbins, MP, Müller, K, Glover, M, Liu, J, Putrianti, ED, Bauza, K, Reyes-Sandoval, A, Matuschewski, K, Silvie, O, Hafalla, JCR

Plasmodium P36 determines host cell receptor usage during sporozoite invasion by Manzoni, G, Marinach, C, Topçu, S, Briquet, S, Grand, M, Tolle, M, Gransagne, M, Lescar, J, Andolina, C, Franetich, J, Zeisel, M, Huby, T, Rubinstein, E, Snounou, G, Mazier, D, Nosten, F, Baumert, T, Silvie, O

Expanding the malaria antibody toolkit: development and characterisation of Plasmodium falciparum RH5, CyRPA, and CSP recombinant human monoclonal antibodies by Nacer, A, Kivi, G, Pert, R, Juronen, E, Holenya, P, Aliprandini, E, Amino, R, Silvie, O, Quinkert, D, Le Duff, Y, Hurley, M, Reimer, U, Tover, A, Draper, SJ, Gilbert, S, Ho, MM, Bowyer, PW